Subband coding for image data archiving

The use of subband coding on image data is discussed. An overview of subband coding is given. Advantages of subbanding for browsing and progressive resolution are presented. Implementations for lossless and lossy coding are discussed. Algorithm considerations and simple implementations of subband systems are given

A reconfigurable multicarrier demodulator architecture

An architecture based on parallel and pipline design approaches has been developed for the Frequency Division Multiple Access/Time Domain Multiplexed (FDMA/TDM) conversion system. The architecture has two main modules namely the transmultiplexer and the demodulator. The transmultiplexer has two pipelined modules. These are the shared multiplexed polyphase filter and the Fast Fourier Transform (FFT). The demodulator consists of carrier, clock, and data recovery modules which are interactive. Progress on the design of the MultiCarrier Demodulator (MCD) using commercially available chips and Application Specific Integrated Circuits (ASIC) and simulation studies using Viewlogic software will be presented at the conference

High speed hardware development for FDMA/TDM system

The development of a transmultiplexor and a quadrature phase shift keying (QPSK) demodulator is discussed. The system is designed to meet real time signal processing requirements of future satellite systems and should consume very little power. The architectures of the transmultiplexor and the demodulator are designed for the pipelining of all the modules, namely the commutator, the filter bank fast fourier transform (FFT), and the internal modules of the QPSK. The architecture is designed for the case of 800 channels. Each channel is to have a bandwidth of 45 KHz and a bit rate of 64 Kb/s. In this case each module will have 22.22 micro seconds to complete a computation

Investigation of Different Constituent Encoders in a Turbo-code Scheme for Reduced Decoder Complexity

A large number of papers have been published attempting to give some analytical basis for the performance of Turbo-codes. It has been shown that performance improves with increased interleaver length. Also procedures have been given to pick the best constituent recursive systematic convolutional codes (RSCC's). However testing by computer simulation is still required to verify these results. This thesis begins by describing the encoding and decoding schemes used. Next simulation results on several memory 4 RSCC's are shown. It is found that the best BER performance at low E(sub b)/N(sub o) is not given by the RSCC's that were found using the analytic techniques given so far. Next the results are given from simulations using a smaller memory RSCC for one of the constituent encoders. Significant reduction in decoding complexity is obtained with minimal loss in performance. Simulation results are then given for a rate 1/3 Turbo-code with the result that this code performed as well as a rate 1/2 Turbo-code as measured by the distance from their respective Shannon limits. Finally the results of simulations where an inaccurate noise variance measurement was used are given. From this it was observed that Turbo-decoding is fairly stable with regard to noise variance measurement

A Single Chip VLSI Implementation of a QPSK/SQPSK Demodulator for a VSAT Receiver Station

This thesis presents a VLSI implementation of a QPSK/SQPSK demodulator. It is designed to be employed in a VSAT earth station that utilizes the FDMA/TDM link. A single chip architecture is used to enable this chip to be easily employed in the VSAT system. This demodulator contains lowpass filters, integrate and dump units, unique word detectors, a timing recovery unit, a phase recovery unit and a down conversion unit. The design stages start with a functional representation of the system by using the C programming language. Then it progresses into a register based representation using the VHDL language. The layout components are designed based on these VHDL models and simulated. Component generators are developed for the adder, multiplier, read-only memory and serial access memory in order to shorten the design time. These sub-components are then block routed to form the main components of the system. The main components are block routed to form the final demodulator

Investigation of the Use of Erasures in a Concatenated Coding Scheme

A new method for declaring erasures in a concatenated coding scheme is investigated. This method is used with the rate 1/2 K = 7 convolutional code and the (255, 223) Reed Solomon code. Errors and erasures Reed Solomon decoding is used. The erasure method proposed uses a soft output Viterbi algorithm and information provided by decoded Reed Solomon codewords in a deinterleaving frame. The results show that a gain of 0.3 dB is possible using a minimum amount of decoding trials

Cancer-selective, single agent chemoradiosensitising gold nanoparticles

Two nanometre gold nanoparticles (AuNPs), bearing sugar moieties and/or thiol-polyethylene glycol-amine (PEG-amine), were synthesised and evaluated for their in vitro toxicity and ability to radiosensitise cells with 220 kV and 6 MV X-rays, using four cell lines representing normal and cancerous skin and breast tissues. Acute 3 h exposure of cells to AuNPs, bearing PEG-amine only or a 50:50 ratio of alpha-galactose derivative and PEG-amine resulted in selective uptake and toxicity towards cancer cells at unprecedentedly low nanomolar concentrations. Chemotoxicity was prevented by co-administration of N-acetyl cysteine antioxidant, or partially prevented by the caspase inhibitor Z-VAD-FMK. In addition to their intrinsic cancer-selective chemotoxicity, these AuNPs acted as radiosensitisers in combination with 220 kV or 6 MV X-rays. The ability of AuNPs bearing simple ligands to act as cancer-selective chemoradiosensitisers at low concentrations is a novel discovery that holds great promise in developing low-cost cancer nanotherapeutics

AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2

Background: Binding and neutralising anti-Spike antibodies play a key role in immune defence against SARS-CoV-2 infection. Since it is known that antibodies wane with time and new immune-evasive variants are emerging, we aimed to assess the dynamics of anti-Spike antibodies in an African adult population with prior SARS-CoV-2 infection and to determine the effect of subsequent COVID-19 vaccination. Methods: Using a prospective cohort design, we recruited adults with prior laboratory-confirmed mild/moderate COVID-19 in Blantyre, Malawi, and followed them up for 270 days (n = 52). A subset of whom subsequently received a single dose of the AstraZeneca COVID-19 vaccine (ChAdOx nCov-19) (n = 12). We measured the serum concentrations of anti-Spike and receptor-binding domain (RBD) IgG antibodies using a Luminex-based assay. Anti-RBD antibody cross-reactivity across SARS-CoV-2 variants of concern (VOC) was measured using a haemagglutination test. A pseudovirus neutralisation assay was used to measure neutralisation titres across VOCs. Ordinary or repeated measures one-way ANOVA was used to compare log10 transformed data, with p value adjusted for multiple comparison using Šídák's or Holm-Šídák's test. Results: We show that neutralising antibodies wane within 6 months post mild/moderate SARS-CoV-2 infection (30–60 days vs. 210–270 days; Log ID50 6.8 vs. 5.3, p = 0.0093). High levels of binding anti-Spike or anti-RBD antibodies in convalescent serum were associated with potent neutralisation activity against the homologous infecting strain (p < 0.0001). A single dose of the AstraZeneca COVID-19 vaccine following mild/moderate SARS-CoV-2 infection induced a 2 to 3-fold increase in anti-Spike and -RBD IgG levels 30 days post-vaccination (both, p < 0.0001). The anti-RBD IgG antibodies from these vaccinated individuals were broadly cross-reactive against multiple VOCs and had neutralisation potency against original D614G, beta, and delta variants. Conclusions: These findings show that the AstraZeneca COVID-19 vaccine is an effective booster for waning cross-variant antibody immunity after initial priming with SARS-CoV-2 infection. The potency of hybrid immunity and its potential to maximise the benefits of COVID-19 vaccines needs to be taken into consideration when formulating vaccination policies in sub-Saharan Africa, where there is still limited access to vaccine doses